EUDAMED modules move from pilot to routine use

The European Database on Medical Devices is being brought into operation module by module rather than in a single launch. Actor registration, UDI and device registration, and certificate notification are the areas where obligations bite first, with vigilance and post-market surveillance modules following later in the sequence. Each module has its own functional specification and its own transition period, which complicates planning for companies operating in several member states.

For manufacturers the technical work is less about the portal and more about internal data. A single device family can generate dozens of basic UDI-DI and UDI-DI combinations once packaging variants and sterile presentations are counted, and those identifiers must reconcile with what appears on labels, in the quality management system, and in the distributor's catalogue. Where those sources disagree, registration stalls until the master data is corrected.

Economic operators also need a valid single registration number before they can act in the database. That has caused friction for importers and for subsidiaries that were previously invisible to regulators, since each legal entity must register separately and appoint the right roles. Groups that centralised regulatory affairs in one country have had to revisit that model, because the actor module ties permissions to the legal entity rather than to the group.

Compliance managers advise treating EUDAMED data as a controlled record rather than a one-off filing. Assigning ownership, versioning changes, and reconciling the database against the label artwork before each release cycle is proving more effective than a periodic clean-up exercise. Several companies now include a database check in the change control checklist, so that a new variant cannot be released until its identifiers have been created and verified.